Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Miyajima

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2018
Inseparable interaction of the prostate and inguinal herniaAkira Miyajima
International Journal of Urology : Official Journal of the Japanese Urological Association|January 17, 2013
Editorial comment to recent advances of natural orifice transluminal endoscopic surgery in urological surgeryAkira Miyajima
Urology|October 22, 2013
Reply: To PMID 24063937Masanori Hasegawa, Akira Miyajima
Urology|September 26, 2013
Reply: To PMID 24063935Gou Kaneko, Akira Miyajima
International Journal of Urology : Official Journal of the Japanese Urological Association|March 29, 2014
Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine-kinase inhibitor and mammalian target of rapamycin inhibitorRyuichi Mizuno, Akira Miyajima, Mototsugu Oya
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Risk factors in localized prostate cancer]Kazuhiro Matsumoto, Akira Miyajima, Mototsugu Oya
Frontiers in Oncology|October 4, 2014
Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?Takeo Kosaka, Akira Miyajima, Mototsugu Oya
Nihon Jinzo Gakkai Shi|September 21, 2012
[Role of mTOR inhibition in the treatment of metastatic renal cell carcinoma]Ryuichi Mizuno, Akira Miyajima, Mototsugu Oya
Urology Case Reports|March 21, 2023
A case of post-BCG therapy renal granuloma concurrent with ureteral carcinomaTatsuya Otaki, Nobuyuki Nakajima, Akira Miyajima
Reviews on Recent Clinical Trials|May 26, 2009
Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital CancerAkira Miyajima, Eiji Kikuchi, Takeo Kosaka, et al.
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2018
Inseparable interaction of the prostate and inguinal herniaAkira Miyajima
International Journal of Urology : Official Journal of the Japanese Urological Association|January 17, 2013
Editorial comment to recent advances of natural orifice transluminal endoscopic surgery in urological surgeryAkira Miyajima
Urology|October 22, 2013
Reply: To PMID 24063937Masanori Hasegawa, Akira Miyajima
Urology|September 26, 2013
Reply: To PMID 24063935Gou Kaneko, Akira Miyajima
International Journal of Urology : Official Journal of the Japanese Urological Association|March 29, 2014
Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine-kinase inhibitor and mammalian target of rapamycin inhibitorRyuichi Mizuno, Akira Miyajima, Mototsugu Oya
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Risk factors in localized prostate cancer]Kazuhiro Matsumoto, Akira Miyajima, Mototsugu Oya
Frontiers in Oncology|October 4, 2014
Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?Takeo Kosaka, Akira Miyajima, Mototsugu Oya
Nihon Jinzo Gakkai Shi|September 21, 2012
[Role of mTOR inhibition in the treatment of metastatic renal cell carcinoma]Ryuichi Mizuno, Akira Miyajima, Mototsugu Oya
Urology Case Reports|March 21, 2023
A case of post-BCG therapy renal granuloma concurrent with ureteral carcinomaTatsuya Otaki, Nobuyuki Nakajima, Akira Miyajima
Reviews on Recent Clinical Trials|May 26, 2009
Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital CancerAkira Miyajima, Eiji Kikuchi, Takeo Kosaka, et al.
Pageof 25